How to treat arterial hypertension.
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002740:Chlorothiazide / Q000627:therapeutic use; D002752:Chlorthalidone / Q000627:therapeutic use; D003299:Cooperative Behavior; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007668:Kidney / Q000187:drug effects; D008750:Methyldopa / Q000627:therapeutic use; D010817:Physician-Patient Relations; D012110:Reserpine / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004232:Diuretics; D013449:Sulfonamides; D006852:Hydrochlorothiazide; D006830:Hydralazine; D013148:Spironolactone; D008750:Methyldopa; D002740:Chlorothiazide; D005665:Furosemide; D012110:Reserpine; D004976:Ethacrynic Acid; D003981:Diazoxide; D002752:Chlorthalidone; D014223:Triamterene; D006145:Guanethidine